The present invention relates to transgenic animals, as well as
compositions and methods relating to the characterization of gene
function. Specifically, the present invention provides transgenic mice
comprising mutations in an endophilin III gene. Such transgenic mice are
useful as models for disease and for identifying agents that modulate
gene expression and gene function, and as potential treatments for
various disease states and disease conditions.